GPX4 and cancer: Furthermore, targeting regulators of ferroptosis, such as AIFM2 [270], glutathione synthetase (GSS), GPX4, FA complementation group D2 (FANCD2), and MAF BZIP transcription factor F (MAFF) can sensitize specific cancers to radiotherapy-dependent ferroptosis [271–275].